ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1253

Novel Nonsense Variant and Entire Deletion of TNFAIP3 Cause Haploinsufficiency of A20 Clinically Distinct from Behçet’s Disease

Naomi Tsuchida1, Yohei Kirino 1, Yutaro Soejima 1, Hideaki Nakajima 1, Satoko Miyatake 2 and Naomichi Matsumoto 2, 1Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine, Yokohama, Japan, 2Department of Human Genetics, Yokohama City University Graduate School of Medicine, Yokohama, Japan

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: Autoinflammation, Behcet's syndrome and genetics

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 11, 2019

Title: Miscellaneous Rheumatic & Inflammatory Disease Poster II: Autoinflammation Related Diseases & Therapies

Session Type: Poster Session (Monday)

Session Time: 9:00AM-11:00AM

Background/Purpose: Haploinsufficiency of A20 (HA20) is caused by loss-of-function TNFAIP3 variants. Phenotypic and genetic features of HA20 remain uncertain; therefore, clinical distinction between HA20 and Behçet’s disease (BD) requires clarification.

Methods: We have collected twelve Japanese BD-like families. Probands of these families were analyzed by whole exome sequencing (WES) and subsequent Sanger sequencing or quantitative PCR. Copy number variants (CNVs) were examined using WES data with two algorithms: the eXome-Hidden Markov Model (XHMM) and a program based on the relative depth of coverage ratios developed by Nord et al. To observe mutational effects of the nonsense variant, RT-PCR was performed. Clinical features were compared between 54 HA20 patients (including previously reported and new cases) and BD cohorts (520 Japanese BD patients accumulated at our facility and pediatric BD from the Pediatric Behçet’s disease (PEDBD) study by Kone-Paut et al.) Statistical analysis was performed with SPSS version 22 (IBM Japan, Tokyo, Japan). Categorical variables were analyzed using the chi-square test. Continuous variables were examined using Student’s t-test. A p value less than 0.05 was considered statistically significant.

Results: Among Twenty-five patients from twelve families, two novel TNFAIP3 pathogenic changes were found in two families (16.7%, 2 of 12): nonsense variant in one family and a 236 kb deletion at 6q23.3 containing TNFAIP3 in another family. The nonsense variant may be subjected to nonsense-mediated mRNA decay (NMD). Four HA20 patients in the two families presented with childhood-onset recurrent oral and genital ulcers and were initially diagnosed and treated as BD. Consistent with the clinical features of HA20, recurrent, refractory fever attacks (3/4), and digestive ulcers (2/4) were observed. A comparison of clinical features between HA20 patients and cohorts of BD patients revealed that some features are shared between HA20 and BD as previously reported: recurrent oral and genital ulcers, and skin, eye, musculoskeletal and gastrointestinal involvement. While several critical features were more specific to HA20: early-onset, familial occurrence, recurrent fever attacks, gastrointestinal involvement, and infrequent ocular involvement (Table 1).

Conclusion: We identified a novel nonsense variant and deletion of the entire TNFAIP3 gene in two unrelated Japanese HA20 families. Genetic screening of TNFAIP3 should be considered for familial BD-like patients with early-onset recurrent fevers.

Table1: Clinical features of haploinsufficiency of A20 -HA20- and Behçet’s disease -BD-


Disclosure: N. Tsuchida, None; Y. Kirino, None; Y. Soejima, None; H. Nakajima, None; S. Miyatake, None; N. Matsumoto, None.

To cite this abstract in AMA style:

Tsuchida N, Kirino Y, Soejima Y, Nakajima H, Miyatake S, Matsumoto N. Novel Nonsense Variant and Entire Deletion of TNFAIP3 Cause Haploinsufficiency of A20 Clinically Distinct from Behçet’s Disease [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/novel-nonsense-variant-and-entire-deletion-of-tnfaip3-cause-haploinsufficiency-of-a20-clinically-distinct-from-behcets-disease/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/novel-nonsense-variant-and-entire-deletion-of-tnfaip3-cause-haploinsufficiency-of-a20-clinically-distinct-from-behcets-disease/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology